Annual FCF
-$98.17 M
-$26.56 M-37.08%
31 December 2023
Summary:
RAPT Therapeutics annual free cash flow is currently -$98.17 million, with the most recent change of -$26.56 million (-37.08%) on 31 December 2023. During the last 3 years, it has fallen by -$57.28 million (-140.10%). RAPT annual FCF is now -247.55% below its all-time high of -$28.25 million, reached on 31 December 2017.RAPT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$17.64 M
+$10.51 M+37.35%
30 September 2024
Summary:
RAPT Therapeutics quarterly free cash flow is currently -$17.64 million, with the most recent change of +$10.51 million (+37.35%) on 30 September 2024. Over the past year, it has increased by +$4.31 million (+19.64%). RAPT quarterly FCF is now -208.75% below its all-time high of -$5.71 million, reached on 31 December 2019.RAPT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$100.80 M
+$4.31 M+4.10%
30 September 2024
Summary:
RAPT Therapeutics TTM free cash flow is currently -$100.80 million, with the most recent change of +$4.31 million (+4.10%) on 30 September 2024. Over the past year, it has dropped by -$7.55 million (-8.10%). RAPT TTM FCF is now -1151.58% below its all-time high of -$8.05 million, reached on 31 March 2018.RAPT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RAPT Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.1% | +19.6% | -8.1% |
| 3 y3 years | -140.1% | -40.1% | -79.2% |
| 5 y5 years | -169.3% | -44.4% | -142.8% |
RAPT Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -140.1% | at low | -40.1% | +39.3% | -79.2% | +4.9% |
| 5 y | 5 years | -170.0% | at low | -208.8% | +39.3% | -224.5% | +4.9% |
| alltime | all time | -247.6% | at low | -208.8% | +39.3% | -1151.6% | +4.9% |
RAPT Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$17.64 M(-37.3%) | -$100.80 M(-4.1%) |
| June 2024 | - | -$28.15 M(+3.5%) | -$105.11 M(-0.8%) |
| Mar 2024 | - | -$27.19 M(-2.3%) | -$106.00 M(+8.0%) |
| Dec 2023 | -$98.17 M(+37.1%) | -$27.82 M(+26.7%) | -$98.17 M(+5.3%) |
| Sept 2023 | - | -$21.95 M(-24.4%) | -$93.25 M(+5.3%) |
| June 2023 | - | -$29.04 M(+50.0%) | -$88.53 M(+17.6%) |
| Mar 2023 | - | -$19.36 M(-15.4%) | -$75.25 M(+5.1%) |
| Dec 2022 | -$71.62 M(+15.9%) | -$22.90 M(+32.9%) | -$71.62 M(+2.6%) |
| Sept 2022 | - | -$17.23 M(+9.3%) | -$69.79 M(+7.1%) |
| June 2022 | - | -$15.76 M(+0.2%) | -$65.15 M(+2.8%) |
| Mar 2022 | - | -$15.73 M(-25.4%) | -$63.37 M(+2.6%) |
| Dec 2021 | -$61.78 M | -$21.07 M(+67.4%) | -$61.78 M(+9.8%) |
| Sept 2021 | - | -$12.59 M(-9.9%) | -$56.25 M(+4.7%) |
| June 2021 | - | -$13.98 M(-1.1%) | -$53.74 M(+16.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$14.14 M(-9.0%) | -$46.18 M(+12.9%) |
| Dec 2020 | -$40.89 M(+12.4%) | -$15.54 M(+54.2%) | -$40.89 M(+31.6%) |
| Sept 2020 | - | -$10.08 M(+56.8%) | -$31.06 M(-6.4%) |
| June 2020 | - | -$6.43 M(-27.3%) | -$33.20 M(-8.2%) |
| Mar 2020 | - | -$8.84 M(+54.8%) | -$36.15 M(-0.6%) |
| Dec 2019 | -$36.36 M(-0.2%) | -$5.71 M(-53.2%) | -$36.36 M(-12.4%) |
| Sept 2019 | - | -$12.21 M(+30.2%) | -$41.51 M(+6.6%) |
| June 2019 | - | -$9.38 M(+3.6%) | -$38.96 M(+4.0%) |
| Mar 2019 | - | -$9.05 M(-16.7%) | -$37.45 M(+2.7%) |
| Dec 2018 | -$36.45 M(+29.1%) | -$10.87 M(+12.5%) | -$36.45 M(+42.5%) |
| Sept 2018 | - | -$9.66 M(+22.7%) | -$25.59 M(+60.6%) |
| June 2018 | - | -$7.88 M(-2.2%) | -$15.93 M(+97.8%) |
| Mar 2018 | - | -$8.05 M | -$8.05 M |
| Dec 2017 | -$28.25 M | - | - |
FAQ
- What is RAPT Therapeutics annual free cash flow?
- What is the all time high annual FCF for RAPT Therapeutics?
- What is RAPT Therapeutics annual FCF year-on-year change?
- What is RAPT Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for RAPT Therapeutics?
- What is RAPT Therapeutics quarterly FCF year-on-year change?
- What is RAPT Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for RAPT Therapeutics?
- What is RAPT Therapeutics TTM FCF year-on-year change?
What is RAPT Therapeutics annual free cash flow?
The current annual FCF of RAPT is -$98.17 M
What is the all time high annual FCF for RAPT Therapeutics?
RAPT Therapeutics all-time high annual free cash flow is -$28.25 M
What is RAPT Therapeutics annual FCF year-on-year change?
Over the past year, RAPT annual free cash flow has changed by -$26.56 M (-37.08%)
What is RAPT Therapeutics quarterly free cash flow?
The current quarterly FCF of RAPT is -$17.64 M
What is the all time high quarterly FCF for RAPT Therapeutics?
RAPT Therapeutics all-time high quarterly free cash flow is -$5.71 M
What is RAPT Therapeutics quarterly FCF year-on-year change?
Over the past year, RAPT quarterly free cash flow has changed by +$4.31 M (+19.64%)
What is RAPT Therapeutics TTM free cash flow?
The current TTM FCF of RAPT is -$100.80 M
What is the all time high TTM FCF for RAPT Therapeutics?
RAPT Therapeutics all-time high TTM free cash flow is -$8.05 M
What is RAPT Therapeutics TTM FCF year-on-year change?
Over the past year, RAPT TTM free cash flow has changed by -$7.55 M (-8.10%)